The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

Topical ABT-263 effectively reduced several senescence markers in aged skin, preparing it for improved wound healing.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...

Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.

Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for ...